| Pharmaceutical active ingredients: |
| Aluminum HydroxideMagnesium Carbonate |
| Available forms, composition and doses of Gaviscon Extra Strength Suspension: |
| Suspension; Oral; Aluminum Hydroxide 254 mg; Magnesium Carbonate 237.5 mg / 15 mlTablets; Oral; Aluminum Hydroxide 160 mg; Magnesium Carbonate 105 mg |
| Gaviscon Extra Strength Suspension medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A02AD01 - Ordinary salt combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| GlaxoSmithKline |